Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page (NCT03370718); the page content appears unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:59.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T07:53:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T04:14:43.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page updates from v3.0.1 to v3.0.2, removing the old revision tag and the 'Back to Top' element. No substantive content changes are indicated.
    Difference
    0.2%
    Check dated 2025-09-14T21:41:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:57:26.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications, including a significant study on cabozantinib for advanced adrenocortical carcinoma. Additionally, several terms related to genetic testing and health services have been added, while some previous location and cancer classification terms have been removed.
    Difference
    6%
    Check dated 2025-08-31T12:17:48.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.